RSS
6 Jan 2020

Lannett Launches Venlafaxine ER Tablets And Lidocaine Topical Solution 4%

Author: admintech | Filed under: Press Release

PHILADELPHIA, Jan. 6, 2020 /PRNewswire/ — Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced marketing Venlafaxine Extended Release (ER) Tablets, 150 mg and 225 mg, USP, and Lidocaine Topical Solution 4%. The estimated IQVIA market values of Venlafaxine ER Tablets,…

This entry was posted on Monday, January 6th, 2020 at 7:11 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»